Sangamo Therapeutics Ratios (2010-2025) | SGMO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)	-173.81%	-169.17%	-166.66%		-155.57%	-146.68%	-200.77%	-189.92%	13.50%	-1,766.93%	-1,094.84%	-2,966.06%	-10,185.24%	-10,127.53%	21.78%	-366.51%	-473.48%	-109.03%	-6,039.76%	-266.88%
EBIT Margin (Quarter)	-176.19%	-174.73%	-169.58%		-160.32%	-155.67%	-207.46%	-203.42%	11.42%	-1,807.93%	-1,132.24%	-3,039.13%	-10,712.27%	-10,416.85%	21.52%	-399.85%	-460.28%	-97.54%	-6,119.28%	-268.51%
EBITDA Margin (Quarter)	-176.19%	-174.73%	-169.58%		-160.32%	-155.67%	-207.46%	-203.42%	11.42%	-1,807.93%	-1,132.24%	-3,039.13%	-10,712.27%	-10,416.85%	21.52%	-399.85%	-460.28%	-97.54%	-6,119.28%	-268.51%
Operating Margin (Quarter)	-176.19%	-174.73%	-169.58%		-160.32%	-155.67%	-207.46%	-203.42%	11.42%	-1,807.93%	-1,132.24%	-3,039.13%	-10,712.27%	-10,416.85%	21.52%	-399.85%	-460.28%	-97.54%	-6,119.28%	-268.51%
Net Margin (Quarter)	-174.81%	-169.23%	-166.96%		-155.92%	-146.96%	-200.89%	-190.87%	13.38%	-1,675.29%	-1,108.35%	-2,952.74%	-10,205.61%	-10,148.31%	18.99%	-359.94%	-475.33%	-109.18%	-6,012.05%	-263.00%
FCF Margin (Quarter)	-272.08%	-232.59%	-157.05%		-216.90%	-204.28%	-186.17%	-269.16%	-48.43%	-969.29%	-365.08%	-2,361.80%	-10,212.68%	-7,544.10%	23.89%	-49.20%	-409.86%	-98.46%	-4,902.75%	-171.42%
Efficiency
Assets Average (Quarter)	907.82M	856.23M	803.88M	747.16M	688.12M	635.72M	605.52M	578.21M	501.54M	382.82M	272.39M	192.51M	147.14M	110.99M	102.14M	106.45M	93.90M	91.86M	93.10M	74.19M
Equity Average (Quarter)	483.39M	457.44M	425.74M	390.68M	354.93M	326.40M	313.72M	302.06M	315.28M	284.63M	184.28M	108.90M	69.79M	40.19M	31.41M	30.95M	13.84M	12.25M	12.92M	-4.01M
Invested Capital (Quarter)	469.42M	445.46M	406.02M	375.34M	334.52M	318.28M	309.15M	294.96M	335.61M	233.64M	134.92M	82.89M	56.70M	23.69M	39.13M	22.77M	4.91M	19.60M	6.24M	-14.27M
Asset Utilization Ratio (Quarter)	0.14	0.16	0.13	0.11	0.12	0.14	0.14	0.19	0.48	0.57	0.74	0.92	0.13	0.11	0.51	0.53	0.67	0.88	0.34	0.53
Leverage & Solvency
Equity Ratio (Quarter)	0.54	0.53	0.53	0.52	0.51	0.52	0.52	0.52	0.76	0.72	0.61	0.50	0.44	0.25	0.35	0.22	0.06	0.20	0.07	-0.24
Valuation
Enterprise Value (Quarter)	-588.02M	-529.65M	-423.41M	-376.55M	-317.80M	-315.72M	-313.57M	-100.44M	-78.24M	-143.10M	-132.11M	-45.20M	-55.33M	-27.79M	-39.20M	-41.92M	-25.18M	-38.34M	-30.51M	-20.95M
Return Ratios
Return on Sales (Quarter)	-1.75%	-1.69%	-1.67%	-2.16%	-1.56%	-1.47%	-2.01%	-1.91%	0.13%	-16.75%	-11.08%	-29.53%	-102.06%	-101.48%	0.22%	-3.60%	-4.75%	-1.09%	-60.12%	-2.63%
Return on Capital Employed (Quarter)	-0.17%	-0.20%	-0.28%	-0.30%	-0.32%	-0.35%	-0.38%	-0.43%	-0.31%	-0.66%	-1.19%	-1.89%	-3.21%	-3.57%	-2.37%	-1.71%	-1.85%	-1.42%	-2.54%	-3.82%
Return on Invested Capital (Quarter)	-0.27%	-0.31%	-0.44%	-0.47%	-0.51%	-0.55%	-0.59%	-0.67%	-0.44%	-0.74%	-1.42%	-2.47%	-4.85%	-6.43%	-4.46%	-3.35%	-5.92%	-5.11%	-8.40%	30.08%
Return on Assets (Quarter)	-0.14%	-0.16%	-0.23%	-0.24%	-0.26%	-0.27%	-0.29%	-0.33%	-0.25%	-0.52%	-0.92%	-1.34%	-2.23%	-2.25%	-1.32%	-0.92%	-0.85%	-0.69%	-1.17%	-1.66%
Return on Equity (Quarter)	-0.26%	-0.30%	-0.43%	-0.46%	-0.50%	-0.53%	-0.57%	-0.64%	-0.40%	-0.70%	-1.35%	-2.37%	-4.70%	-6.21%	-4.29%	-3.16%	-5.74%	-5.17%	-8.43%	30.64%

Research Tools

Sangamo Therapeutics Ratios (2010-2025) | SGMO

Create an account

Sign In

Reset Password